These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34243920)

  • 21. Evaluation of non-contrast magnetic resonance imaging as an imaging surveillance tool for hepatocellular carcinoma in at-risk patients.
    Liu JKJ; Lee CH; Tan CH
    Singapore Med J; 2022 Apr; 63(4):203-208. PubMed ID: 32798363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI.
    Brunsing RL; Fowler KJ; Yokoo T; Cunha GM; Sirlin CB; Marks RM
    Hepatoma Res; 2020; 6():. PubMed ID: 33381651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis.
    Ayuso C; Forner A; Darnell A; Rimola J; García-Criado Á; Bianchi L; Vilana R; Oliveira R; Llarch N; Bruix J
    Liver Int; 2019 Jul; 39(7):1281-1291. PubMed ID: 31077539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas.
    Whang S; Choi MH; Choi JI; Youn SY; Kim DH; Rha SE
    Eur Radiol; 2020 Aug; 30(8):4150-4163. PubMed ID: 32166493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.
    Chen BB; Hsu CY; Yu CW; Liang PC; Hsu C; Hsu CH; Cheng AL; Shih TT
    Radiology; 2016 Nov; 281(2):454-464. PubMed ID: 27171020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI-based risk factors of hepatocellular carcinoma in patients with chronic liver disease: A prospective observational study.
    Shimizu T; Motosugi U; Komatsu N; Ichikawa S; Inoue T; Onishi H; Enomoto N
    J Magn Reson Imaging; 2020 Feb; 51(2):389-396. PubMed ID: 31120640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.
    Choi JY; Lee JM; Sirlin CB
    Radiology; 2014 Oct; 273(1):30-50. PubMed ID: 25247563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abbreviated MRI Protocol for the Assessment of Ablated Area in HCC Patients.
    Granata V; Grassi R; Fusco R; Setola SV; Belli A; Piccirillo M; Pradella S; Giordano M; Cappabianca S; Brunese L; Grassi R; Petrillo A; Izzo F
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33808466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
    Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
    Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging.
    Kim SM; Shin SS; Lee BC; Kim JW; Heo SH; Lim HS; Jeong YY
    Abdom Radiol (NY); 2017 Oct; 42(10):2527-2537. PubMed ID: 28409202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI in the evaluation of hepatocellular nodules: role of pulse sequences and contrast agents.
    Ichikawa T
    Intervirology; 2004; 47(3-5):252-70. PubMed ID: 15383734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging.
    Min JH; Kim YK; Choi SY; Kang TW; Jeong WK; Kim K; Won HJ
    Br J Radiol; 2018 Oct; 91(1090):20180177. PubMed ID: 29927634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.
    Dioguardi Burgio M; Picone D; Cabibbo G; Midiri M; Lagalla R; Brancatelli G
    Abdom Radiol (NY); 2016 Aug; 41(8):1546-54. PubMed ID: 27052455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
    Park YS; Lee CH; Kim JW; Shin S; Park CM
    World J Gastroenterol; 2016 Jan; 22(1):284-99. PubMed ID: 26755877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver.
    Yamashita Y; Mitsuzaki K; Yi T; Ogata I; Nishiharu T; Urata J; Takahashi M
    Radiology; 1996 Jul; 200(1):79-84. PubMed ID: 8657948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Advances in Magnetic Nanoparticle-based Molecular Probes for Hepatocellular Carcinoma Diagnosis and Therapy.
    Zhang Q; Wang S; Qiao R; Whittaker MR; Quinn JF; Davis TP; Li H
    Curr Pharm Des; 2018; 24(21):2432-2437. PubMed ID: 29788872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR Imaging Contrast Agents: Role in Imaging of Chronic Liver Diseases.
    Chang SD; Cunha GM; Chernyak V
    Magn Reson Imaging Clin N Am; 2021 Aug; 29(3):329-345. PubMed ID: 34243921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?
    Ruff C; Grözinger G; Syha R; Elser S; Partovi S; Bitzer M; Horger M; Nikolaou K; Grosse U
    J Vasc Interv Radiol; 2019 Mar; 30(3):380-389.e4. PubMed ID: 30819480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
    Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
    Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Hepatic Perfusion Using GRASP MRI: Bringing Liver MRI on a New Level.
    Weiss J; Ruff C; Grosse U; Grözinger G; Horger M; Nikolaou K; Gatidis S
    Invest Radiol; 2019 Dec; 54(12):737-743. PubMed ID: 31206392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.